Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 28, 2020

SELL
$36.66 - $41.78 $36,660 - $41,780
-1,000 Closed
0 $0
Q4 2018

Feb 06, 2019

SELL
$31.89 - $38.44 $6,378 - $7,688
-200 Reduced 16.67%
1,000 $38,000
Q3 2018

Oct 18, 2018

SELL
$29.25 - $36.73 $5,850 - $7,345
-200 Reduced 14.29%
1,200 $42,000
Q2 2018

Aug 07, 2018

BUY
$28.49 - $35.06 $39,886 - $49,084
1,400 New
1,400 $44,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.56B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Quad Cities Investment Group, LLC Portfolio

Follow Quad Cities Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quad Cities Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quad Cities Investment Group, LLC with notifications on news.